Asco Gu 2020 - Search Videos

We’re presenting updated interim results from our Ph 1b/2 clinical trial in first-line metastatic #bladdercancer at ASCO #GU20. Read about the findings here: bit.ly/31JZnQs | Astellas Pharma US

We’re presenting updated interim results from our Ph 1b/2 clinical tri…

371 viewsFeb 10, 2020

FacebookAstellas Pharma US

ASCO GU 2022 on Futibatinib + Pembro in Advanced/Metastatic UC: Preliminary Safety Results From a Phase 2 Study

ASCO GU 2022 on Futibatinib + Pembro in Advanced/Metastatic U…

132 viewsFeb 26, 2022

Invest in yourself at #GU25! Stay ahead of the rapidly evolving landscape in precision medicine and emerging treatments for GU cancers. Discover what's waiting for you at #GU25! | American Society of Clinical Oncology

Invest in yourself at #GU25! Stay ahead of the rapidly evolving land…

40.2K viewsNov 26, 2024

FacebookAmerican Society of Clinical Oncology

DEADLINE APPROACHING! The 2026 ASCO GU Cancers Symposium is The Place to Be Heard. Go beyond the data; share your perspectives, build relationships, and help drive innovation in the field to improve patient-centered care. Submit TODAY! #GU26 | American Society of Clinical Oncology

DEADLINE APPROACHING! The 2026 ASCO GU Cancers Symposiu…

31.2K views4 months ago

FacebookAmerican Society of Clinical Oncology

Paradigm-shifting discoveries and transformative discussions are waiting at ASCO GU Cancers Symposium, The Place to Be! Stay up to date on emerging treatment advances and strategies that will help drive innovation and improve patient-centered care in your practice. #GU26 | American Society of Clinical Oncology | Facebook

Paradigm-shifting discoveries and transformative discussions are wa…

60.5K views3 weeks ago

FacebookAmerican Society of Clinical Oncology

ASCO GU 2023 Longitudinal Detection of ctDNA in Patients With Advanced Renal Cell Carcinoma Featuring Dr. Basu and Dr. Park

ASCO GU 2023 Longitudinal Detection of ctDNA in Patients Wit…

262 viewsFeb 18, 2023

48 reactions | #GU24 is the premier venue for innovations and research that are changing GU cancer care. Join your peers to celebrate 20 years of this important gathering and scientific advancement! | American Society of Clinical Oncology | Facebook

48 reactions | #GU24 is the premier venue for innovations and researc…

4.4K views2 weeks ago

FacebookAmerican Society of Clinical Oncology

The 2026 ASCO GU Cancers Symposium is The Place to Be He…

19.6K views3 weeks ago

FacebookAmerican Society of Clinical Oncology

Dr Neal Shore presents highlights from ASCO GU 2025 on non-musc…

2K views2 weeks ago

FacebookMedthority

ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate C…

13 reactions · 20 shares | ASCO and Google Cloud launch the ASCO G…

41.2K views2 weeks ago

FacebookAmerican Society of Clinical Oncology

ASCO® GU 2025 Summary: The Promise of ADCs in Combination …

241 views11 months ago

ASCO® GU 2025 Summary: Adjuvant Therapy in RCC - A Pract…

118 views11 months ago

ASCO® GU 2025 Insights: Neoadjuvant Durvalumab Chemo i…

65 views11 months ago

ASCO® GU 2025 Insights: mCRPC Survival Outcomes With 177Lu-PS…

147 views11 months ago

ASCO® GU 2025 Summary: Striving Toward New Frontiers in Clear Cel…

204 views11 months ago

Prostate Cancer Highlights From ASCO 2025

ASCO 2025 VL

ASCO 2024: Key Insights Into Enhancing Treatment Efficacy an…

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-…

2.7K viewsFeb 8, 2024

ASCO® GU 2025 Insights: 52-Week Safety and Tolerability of Relugoli…

ASCO® GU 2025 Summary: The Future of Biomarkers in RCC

120 views10 months ago

ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial C…

431 viewsFeb 6, 2024

ASCO® GU 2025 Summary: Advances in Metastatic Prostate C…

219 views11 months ago

ASCO® GU 2025 Insights: Retreatment With EV/Pembro or IC…

241 views11 months ago

ASCO® GU 2025 Summary: Perioperative Strategies in MIBC - …

373 views11 months ago

ASCO® GU 2025 Insights: Perioperative Sacituzumab Govite…

39 views9 months ago

ASCO® GU 2025 Insights: Optimizing Immunotherapy Strate…

29 views11 months ago

ASCO® GU 2025 Insights: Adjuvant Nivo vs. Placebo in High-Risk MIU…

104 views11 months ago

ASCO® GU 2024 Insights: "Real-World Comparison of PSA Respon…

263 viewsFeb 1, 2024

See more videos